TY - JOUR
TI - Casirivimab and imdevimab for COVID-19
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2022
ET - 2022/02/28
VL - 45
IS - 2
SP - 58
EP - 59
DO - 10.18773/austprescr.2022.013
LA - eng
UR - https://australianprescriber.tg.org.au/articles/casirivimab-and-imdevimab-for-covid-19.html
KW - casirivimab
KW - COVID-19
KW - imdevimab
KW - Ronapreve
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -